COMMUNIQUÉS West-GlobeNewswire

Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
12/08/2025
Secured over $111 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by over $71 million in committed capital from Medtronic [...]
Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update
12/08/2025
Commenced site activation for REVEAL pivotal trial in accordance with previously aligned upon key design elements, following receipt of No Objection Letter (NOL) from Health Canada and feedback from the FDA; patient [...]

Pages